I am not certain if my reply on NYT was incomplete
Post# of 155357
(Total Views: 1069)
Posted On: 08/14/2020 9:41:58 PM
I am not certain if my reply on NYT was incomplete , is just what I copied to share here.
Just to be safe, I replied once more to mockingjay:
@mockingjay
In a double blinded,
placebo controlled study, Leronlimab demonstrated statistically significant improvement in NEWS2 (National Early Warning Score), a widely accepted UK clinical metric for measuring the progression of COVID into the severe/critical phase. (P=0.02). Leronlimab increased the number of patients who showed clinical improvement in the NEWS2 score, by 150%.
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
https://clinicaltrials.gov/ct2/show/NCT043436...amp;rank=3
The MOA for leronlimab reducing viremia, reversing cytokine storm and restoring immune function has need described by Dr. Bruce Patterson, a virologist formerly at Stanford.
Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277012/
This should be sufficient to demonstrate this is real. You can go to Cytodyn.com, but these other sources are independent.
Just to be safe, I replied once more to mockingjay:
@mockingjay
In a double blinded,
placebo controlled study, Leronlimab demonstrated statistically significant improvement in NEWS2 (National Early Warning Score), a widely accepted UK clinical metric for measuring the progression of COVID into the severe/critical phase. (P=0.02). Leronlimab increased the number of patients who showed clinical improvement in the NEWS2 score, by 150%.
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
https://clinicaltrials.gov/ct2/show/NCT043436...amp;rank=3
The MOA for leronlimab reducing viremia, reversing cytokine storm and restoring immune function has need described by Dr. Bruce Patterson, a virologist formerly at Stanford.
Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277012/
This should be sufficient to demonstrate this is real. You can go to Cytodyn.com, but these other sources are independent.
(12)
(0)